Juvenile Idiopathic Arthritis Clinical Trials

221 clinical trials for Juvenile Idiopathic Arthritis across international registries, including 39 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. — RECRUITING · PHASE3
• OLE Study With Filgotinib in JIA — RECRUITING · PHASE3
• A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis — RECRUITING · PHASE3
• Feasibility of a Diet Intervention for Juvenile Arthritis — RECRUITING · NA
• Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions — RECRUITING
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases — RECRUITING · PHASE4
• Pain in Juvenile Arthritis — RECRUITING · NA
• Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA — RECRUITING
• A multicenter, randomized open-label study to assess the efficacy, safety, and pharmacokinetics of upadacitinib with a tocilizumab reference arm in subjects from 1 year to less than 18 years old with active systemic juvenile idiopathic arthritis. — RECRUITING · PHASE3
• A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS) — RECRUITING · PHASE2
• The BRIDGE Pain Study — RECRUITING
• Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis — RECRUITING · PHASE2
• Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea — RECRUITING
• Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis — RECRUITING · PHASE3
• Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis — RECRUITING · NA
• Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients — RECRUITING
• Angiogenic Biomarkers in Juvenile Idiopathic Arthritis — RECRUITING
• Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation — RECRUITING
• Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized clinical trial comparing early versus late drug withdrawal combining imaging and multi-Omics. — RECRUITING · PHASE4
• Quantification & Classification of Inflammatory Cells in Uveitis Using OCT — RECRUITING
• CAPRI National Juvenile Idiopathic Arthritis Registry — RECRUITING
• M3-JIA: Making Mindfulness Matter for Children With JIA — RECRUITING · NA
• Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults — RECRUITING
• Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis — RECRUITING
• Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial — RECRUITING · PHASE4
• Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases — RECRUITING · PHASE1
• Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis — RECRUITING · NA
• Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study. — RECRUITING
• Virtual Self-Management Program for JIA — RECRUITING · NA
• UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease — RECRUITING
• Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA — RECRUITING · NA
• AN OPEN-LABEL MULTIPLE-DOSE STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF UPADACITINIB IN PEDIATRIC SUBJECTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS — RECRUITING
• Health and Exercise Response in Children With Chronic and Auto-immune Pathologies — RECRUITING · NA
• AN OPEN-LABEL, SEQUENTIAL, ASCENDING, REPEATED DOSE-FINDING STUDY OF SARILUMAB, ADMINISTERED WITH SUBCUTANEOUS (SC) INJECTION, IN CHILDREN AND ADOLESCENTS, AGED 1 TO 17 YEARS, WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA), FOLLOWED BY AN EXTENSION PHASE — RECRUITING
• A LONG TERM, OPEN LABEL FOLLOW UP STUDY OF CP 690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA) — RECRUITING
• A MULTICENTER, OPEN-LABEL TRIAL OF INTRAVENOUS GOLIMUMAB A HUMAN ANTI-TNFA ANTIBODY, IN PEDIATRIC SUBJECTS WITH ACTIVE POLYARTICULAR COURSE JUVENILE IDIOPATHIS ARTHRITIS DESPITE METHOTREXATE THERAPY — RECRUITING
• B-SPECIFIC 4 PATIENTS: STUDY OF PEDIATRIC EFFICACY AND SAFETY WITH FIRST-LINE USE OF CANAKINUMAB: AN OPEN-LABEL CANAKINUMAB (ACZ885) DOSE REDUCTION OR DOSE INTERVAL PROLONGATION EFFICACY AND SAFETY STUDY IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS — RECRUITING
• "A PHASE IBM OPEN-LABEL, MULTI-CENTER STUDY TO INVESTIGATE THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF TOCILIZUMAB FOLLOWING SUBCUTANEOUS ADMINISTRATION TO PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS." — RECRUITING · PHASE1
• "A PHASE IB, OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE PHARMACOKINETICS, PHARMACODYNAMIS, AND SAFETY OF TOCILIZUMAB FOLLOWING SUBCUTANEOUS ADMINISTRATION TO PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS." — RECRUITING · PHASE1
• Study evaluating safety and effectiveness in children with childhood arthritis — OTHER · PHASE4
• A study to investigate the safety of additional treatment with Vitamin B3 in children with Juvenile Idiopathic Arthritis (JIA) — OTHER · PHASE2
• A study to investigate Vitamin B3 concentrations in the joint after intake — ACTIVE_NOT_RECRUITING · PHASE2
• Compassionate Use Study of Adalimumab in Children 2 to < 4 Years Old or Age 4 and Above Weighing Less Than 15 kg with Active Juvenile Idiopathic Arthritis (JIA) — OTHER · PHASE3
• Efficacy Study Of Tofacitinib In Pediatric JIA Population — COMPLETED · PHASE3
• Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA) — NOT_YET_RECRUITING · PHASE3
• Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis — WITHDRAWN
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis — ACTIVE_NOT_RECRUITING · PHASE1
• An open-label, multiple dose, multicenter study to evaluate the pharmacokinetics, safety, and tolerability of filgotinib in children and adolescents from 8 to less than 18 years of age with juvenile idiopathic arthritis — OTHER · PHASE1
• Short-Term Effects of Intra-Articular Corticosteroid Injection on Knee Function in Juvenile Idiopathic Arthritis — COMPLETED
• Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA) — TERMINATED · PHASE1

Refine this search